Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zilvinas Venclovas

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Central European Journal of Urology|November 14, 2019
Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancerDaimantas Milonas, Zilvinas Venclovas, Mindaugas Jievaltas
Frontiers in Oncology|December 12, 2019
Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer PatientsZilvinas Venclovas, Mindaugas Jievaltas, Daimantas Milonas
Cancers|June 2, 2021
The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological OutcomesDaimantas Milonas, Zilvinas Venclovas, Gustas Sasnauskas, et al.
Cancers|April 30, 2021
Impact of Grade Groups on Prostate Cancer-Specific and Other-Cause Mortality: Competing Risk Analysis from a Large Single Institution SeriesDaimantas Milonas, Tomas Ruzgas, Zilvinas Venclovas, et al.
Central European Journal of Urology|May 13, 2020
External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancerDaimantas Milonas, Zilvinas Venclovas, Tim Muilwijk, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 6, 2021
Benefits and harms of the new prostate cancer grade grouping on the prediction of long-term oncological outcomes in patients after radical prostatectomyDaimantas Milonas, Tim Muilwijk, Zilvinas Venclovas, et al.
Biomed Research International|March 17, 2017
Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate CancerDaimantas Milonas, Zilvinas Venclovas, Inga Gudinaviciene, et al.
Medicina (Kaunas, Lithuania)|June 27, 2024
Primary Renal Angiosarcoma: Rare Tumour with Lethal OutcomesZilvinas Venclovas, Aurelija Alksnyte, Urte Rimsaite, et al.
Journal of Clinical Medicine|April 3, 2021
Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram ThresholdZilvinas Venclovas, Tim Muilwijk, Aivaras J Matjosaitis, et al.
Journal of Clinical Medicine|September 13, 2025
Rare and Aggressive Disease: Urinary Bladder LeiomyosarcomaZilvinas Venclovas, Kotryna Simkunaite, Vaidas Pijadin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Central European Journal of Urology|November 14, 2019
Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancerDaimantas Milonas, Zilvinas Venclovas, Mindaugas Jievaltas
Frontiers in Oncology|December 12, 2019
Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer PatientsZilvinas Venclovas, Mindaugas Jievaltas, Daimantas Milonas
Cancers|June 2, 2021
The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological OutcomesDaimantas Milonas, Zilvinas Venclovas, Gustas Sasnauskas, et al.
Cancers|April 30, 2021
Impact of Grade Groups on Prostate Cancer-Specific and Other-Cause Mortality: Competing Risk Analysis from a Large Single Institution SeriesDaimantas Milonas, Tomas Ruzgas, Zilvinas Venclovas, et al.
Central European Journal of Urology|May 13, 2020
External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancerDaimantas Milonas, Zilvinas Venclovas, Tim Muilwijk, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 6, 2021
Benefits and harms of the new prostate cancer grade grouping on the prediction of long-term oncological outcomes in patients after radical prostatectomyDaimantas Milonas, Tim Muilwijk, Zilvinas Venclovas, et al.
Biomed Research International|March 17, 2017
Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate CancerDaimantas Milonas, Zilvinas Venclovas, Inga Gudinaviciene, et al.
Medicina (Kaunas, Lithuania)|June 27, 2024
Primary Renal Angiosarcoma: Rare Tumour with Lethal OutcomesZilvinas Venclovas, Aurelija Alksnyte, Urte Rimsaite, et al.
Journal of Clinical Medicine|April 3, 2021
Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram ThresholdZilvinas Venclovas, Tim Muilwijk, Aivaras J Matjosaitis, et al.
Journal of Clinical Medicine|September 13, 2025
Rare and Aggressive Disease: Urinary Bladder LeiomyosarcomaZilvinas Venclovas, Kotryna Simkunaite, Vaidas Pijadin, et al.
Pageof 2